MoonLake Immunotherapeutics MLTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CH • USD

SharesGrow Score

49/100

2/6 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para MoonLake Immunotherapeutics (MLTX), incluyendo 19 compras y 31 ventas. El total de compras internas fue valorado en $21.58M y el total de ventas internas en $61.99M.

Internos destacados con actividad reciente incluyen Bvf Partners L P/il, Santos Da Silva Jorge, Bodenstedt Matthias. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — MLTX

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-03-31	Bvf Partners L P/il	10 Percent Owner	Venta Informativa	248,530	$16.79	$4.17M	1,039,238
2026-01-07	Santos Da Silva Jorge	Chief Executive Officer	Concesión de RSU	520,342	$11.29	$5.87M	520,342
2026-01-07	Bodenstedt Matthias	Chief Financial Officer	Concesión de RSU	354,296	-	-	1,276,305
2026-01-07	Reich Kristian	Chief Scientific Officer	Concesión de RSU	520,342	$11.29	$5.87M	520,342
2025-12-19	Santos Da Silva Jorge	Chief Executive Officer	Devolución de Acciones	196,316	-	-	-
2025-12-19	Bodenstedt Matthias	Chief Financial Officer	Conversión (Venta)	8,754	-	-	-
2025-12-19	Reich Kristian	Chief Scientific Officer	Devolución de Acciones	35,389	-	-	-
2025-12-09	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	70,000	$14.49	$1.01M	2,878,577
2025-12-09	Reich Kristian	Chief Scientific Officer	Venta Informativa	72,908	$14.43	$1.05M	-
2025-12-08	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	130,000	$15.08	$1.96M	2,948,577
2025-12-08	Reich Kristian	Chief Scientific Officer	Venta Informativa	130,000	$15.08	$1.96M	72,908
2025-10-08	Bodenstedt Matthias	Chief Financial Officer	Compra Informativa	10,870	$9.09	$98.81K	627,536
2025-09-30	Chen Bihua	Other: Former 10% Owner	Venta Informativa	5,827	$6.96	$40.56K	1,994,173
2025-09-29	Chen Bihua	Other: Former 10% Owner	Venta Informativa	2,800,000	$6.61	$18.51M	2,000,000
2025-09-02	Reich Kristian	Chief Scientific Officer	Devolución de Acciones	48,978	-	-	35,389
2025-07-03	Moukheibir Catherine	Director	Venta Informativa	23,500	$48.79	$1.15M	-
2025-06-05	Bvf Partners L P/il	10 Percent Owner	Concesión de RSU	6,682	$48.83	$326.28K	6,682
2025-06-05	Moukheibir Catherine	Director	Concesión de RSU	6,682	$48.83	$326.28K	6,682
2025-06-05	Loy Spike	Director	Concesión de RSU	6,682	$48.83	$326.28K	6,682
2025-06-05	Xavier Ramnik	Director	Concesión de RSU	6,682	$48.83	$326.28K	6,682
2025-06-05	Sturge Simon	Director	Concesión de RSU	6,682	$48.83	$326.28K	6,682
2025-06-05	Phillips Andrew John	Director	Concesión de RSU	6,682	$48.83	$326.28K	6,682
2025-02-27	Santos Da Silva Jorge	Chief Executive Officer	Concesión de RSU	95,763	-	-	3,078,577
2025-02-27	Bodenstedt Matthias	Chief Financial Officer	Concesión de RSU	95,763	-	-	616,666
2025-02-27	Reich Kristian	Chief Scientific Officer	Concesión de RSU	139,273	$41.77	$5.82M	139,273
2025-01-20	Reich Kristian	Chief Scientific Officer	Conversión (Venta)	1,456	-	-	1,052
2025-01-20	Reich Kristian	Chief Scientific Officer	Conversión (Venta)	3,328	-	-	2,508
2024-10-04	Bvf Partners L P/il	10 Percent Owner	Venta Informativa	132,549	$50.00	$6.63M	1,287,768
2024-10-04	Sturge Simon	Director	Venta Informativa	171,000	$53.72	$9.19M	171,980
2024-06-06	Moukheibir Catherine	Director	Concesión de RSU	7,688	$42.44	$326.28K	7,688
2024-06-06	Loy Spike	Director	Concesión de RSU	7,688	$42.44	$326.28K	7,688
2024-06-06	Xavier Ramnik	Director	Concesión de RSU	7,688	$42.44	$326.28K	7,688
2024-06-06	Sturge Simon	Director	Concesión de RSU	7,688	$42.44	$326.28K	7,688
2024-06-06	Phillips Andrew John	Director	Concesión de RSU	7,688	$42.44	$326.28K	7,688
2024-06-06	Bvf Partners L P/il	10 Percent Owner	Concesión de RSU	7,688	$42.44	$326.28K	7,688
2024-02-29	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	4,740	$55.89	$264.92K	2,982,814
2024-02-28	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	56,065	$55.00	$3.08M	2,987,554
2024-02-28	Reich Kristian	Chief Scientific Officer	Venta Informativa	28,090	$55.00	$1.54M	41,981
2024-02-27	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	62,810	$55.00	$3.45M	3,043,619
2024-02-27	Reich Kristian	Chief Scientific Officer	Venta Informativa	29,431	$55.00	$1.62M	70,071
2024-02-21	Reich Kristian	Chief Scientific Officer	Venta Informativa	569	$55.30	$31.47K	99,502
2024-02-21	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	1,125	$55.27	$62.18K	3,106,429
2024-02-20	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	20,000	$57.44	$1.15M	3,107,554
2024-02-20	Reich Kristian	Chief Scientific Officer	Venta Informativa	10,000	$57.43	$574.3K	100,071
2024-02-16	Reich Kristian	Chief Scientific Officer	Venta Informativa	10,000	$60.15	$601.5K	110,071
2024-02-16	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	20,000	$60.15	$1.2M	3,127,554
2024-02-15	Reich Kristian	Chief Scientific Officer	Venta Informativa	10,000	$60.16	$601.6K	120,071
2024-02-15	Santos Da Silva Jorge	Chief Executive Officer	Venta Informativa	20,000	$60.18	$1.2M	3,147,554
2024-02-14	Reich Kristian	Chief Scientific Officer	Venta Informativa	10,000	$62.43	$624.3K	130,071
2023-12-20	Bodenstedt Matthias	Chief Financial Officer	Venta Informativa	5,264	$58.34	$307.1K	520,903

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento